Insulin icodec Injection

BIOLOGICAL2 trials

Sponsors

Innovent Biologics (Suzhou) Co. Ltd., The United Bio-Technology (Hengqin) Co., Ltd.

Conditions

Healthy PersonType 2 Diabetes Mellitus (T2DM)

Phase 1

Clinical Trials of IBI3035 in Healthy Subjects

RecruitingNCT07591519

Innovent Biologics (Suzhou) Co. Ltd.Healthy Person

Start: 2026-05-08End: 2027-08-31Target: 144Updated: 2026-07-16

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males

RecruitingNCT07630233

The United Bio-Technology (Hengqin) Co., Ltd.Type 2 Diabetes Mellitus (T2DM)

Start: 2026-06-17End: 2026-10-25Target: 53Updated: 2026-09-15